Chip Clark

Track

Insider profile

Currently holds a position at Genocea Biosciences Inc

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 26% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Genocea Biosciences Inc Feb. 1, 2011 -
Independent Director X4 Pharmaceuticals Inc Sept. 1, 2017 - March 13, 2019
Chip Clark's trades of Ibio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Ibio Inc (IBIO)
Transaction date
Purchase
Price
437.22
Quantity 78,445 -46.6%
Value US$427,536
Transaction date
Purchase
Price
2.06
Quantity 4,760 +inf%
Value US$9,806
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-13 2025-01-10
US Ibio Inc (IBIO)
B Purchase
78,445 -46.6%
437.22
US$427,536 		78,445 -46.6% 437.22 US$427,536
2022-06-03 2022-06-02
S Sale
90,498 +25.8%
80.37
US$4,373,342 		90,498 +25.8% 80.37 US$4,373,342
2022-06-02 2022-05-31
S Sale
15,970 -17.0%
439.59
US$2,720,552 		15,970 -17.0% 439.59 US$2,720,552
2022-04-05 2022-04-04
S Sale
3,924 -1.1%
1.25
US$4,905 		3,924 -1.1% 1.25 US$4,905
2022-03-17 2022-03-16
S Sale
11,435 -3.0%
1.10
US$12,578 		11,435 -3.0% 1.10 US$12,578
2020-11-10 2020-11-10
B Purchase
4,760 +inf%
2.06
US$9,806 		4,760 +inf% 2.06 US$9,806